Utah Medical Cannabis Sales Reach Nearly $17 Million in August, Bringing 2026 Total to $134 Million
- Utah's medical cannabis sales reached nearly $17 million in August 2026, bringing the total for the first eight months to approximately $134.8 million.
- August sales included $8.47 million in cartridges and pens, $5.53 million in flower, $2.73 million in infused edibles, and smaller amounts in other product categories, with a 2.4% decrease from July's record sales.
- The state now has 117,158 active medical cannabis patients, with the largest patient age group being 31 to 40 years old, and persistent pain as the most common qualifying condition.
- In the past 30 days, 65,228 patients made at least one purchase, and over 90 days, nearly 90,000 patients made purchases; Utah’s medical cannabis program started in 2018 with no recreational sales permitted.
Utah medical cannabis sales reached nearly $17 million in August, bringing the state’s total for the first eight months of 2026 to approximately $134.8 million, according to the newest monthly report from the Utah Department of Health and Human Services and Utah Department of Agriculture and Food.
August sales totaled $16,995,500 based on the product-category figures listed in the report. The total includes $8,467,100 in cartridges and pens, $5,534,800 in flower, $2,734,500 in infused edibles, $119,200 in infused non-edible products and $139,900 in non-medicated products.
Sales decreased by $418,400, or about 2.4%, from the record $17,413,900 reported in July.
The new year-to-date total was calculated by adding August’s $16,995,500 in sales to the approximately $117.8 million recorded during the first seven months of the year.
Utah now has 117,158 patients with active medical cannabis cards, an increase of 981 from the 116,177 listed in the July report. The state also has 1,035 registered recommending medical providers, 155 paper-only recommending providers, 989 pharmacy agents, 951 processor or cultivator agents and 478 courier agents.
Among active patients, the largest age group was 31 to 40, with 30,644 patients, followed by those ages 41 to 50 at 26,111 and those ages 21 to 30 at 25,608. Patients 65 and older accounted for 13,118 cardholders.
Persistent pain remained by far the most common qualifying condition, with more than 102,000 patients, followed by PTSD with more than 5,400. Nausea and cancer were also among the most common qualifying conditions.
The report shows 65,228 patients made at least one purchase during the previous 30 days, while 37,301 made two or more purchases and 22,857 made at least three. Over the previous 90 days, 89,864 patients made at least one purchase.
Utah legalized medical cannabis in 2018, with the state’s first medical cannabis pharmacy opening in March 2020. The program does not allow recreational marijuana sales.